| 000 | 01675 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516211439.0 | ||
| 264 | 0 | _c20140924 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/cei.12370 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBellemore, S M | |
| 245 | 0 | 0 |
_aAnti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cSep 2014 |
||
| 300 |
_a732-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdoptive Transfer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoproteins E _xadministration & dosage |
| 650 | 0 | 4 |
_aCD11c Antigen _xmetabolism |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDendritic Cells _xcytology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aInterferon-alpha _xbiosynthesis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 700 | 1 | _aNikoopour, E | |
| 700 | 1 | _aAu, B C Y | |
| 700 | 1 | _aKrougly, O | |
| 700 | 1 | _aLee-Chan, E | |
| 700 | 1 | _aHaeryfar, S M | |
| 700 | 1 | _aSingh, B | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 177 _gno. 3 _gp. 732-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12370 _zAvailable from publisher's website |
| 999 |
_c23784550 _d23784550 |
||